| A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation V Saluja, JP Amorij, JC Kapteyn, AH De Boer, HW Frijlink, WLJ Hinrichs Journal of Controlled Release 144 (2), 127-133, 2010 | 242 | 2010 |
| Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses … JP Amorij, V Saluja, AH Petersen, WLJ Hinrichs, A Huckriede, HW Frijlink Vaccine 25 (52), 8707-8717, 2007 | 213 | 2007 |
| Towards tailored vaccine delivery: needs, challenges and perspectives JP Amorij, GFA Kersten, V Saluja, WF Tonnis, WLJ Hinrichs, B Slütter, ... Journal of Controlled Release 161 (2), 363-376, 2012 | 145 | 2012 |
| Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures F Geeraedts, V Saluja, W ter Veer, JP Amorij, HW Frijlink, J Wilschut, ... The AAPS journal 12, 215-222, 2010 | 79 | 2010 |
| Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics M Tafaghodi, V Saluja, GFA Kersten, H Kraan, B Slütter, JP Amorij, ... Vaccine 30 (36), 5341-5348, 2012 | 74 | 2012 |
| Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant V Saluja, JP Amorij, ML van Roosmalen, K Leenhouts, A Huckriede, ... The AAPS journal 12, 109-116, 2010 | 74 | 2010 |
| Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl) 1H-imidazole] in renal tubular cells … J Prakash, M Sandovici, V Saluja, M Lacombe, RQJ Schaapveld, ... Journal of Pharmacology and Experimental Therapeutics 319 (1), 8-19, 2006 | 66 | 2006 |
| Stability of lysozyme in aqueous extremolyte solutions during heat shock and accelerated thermal conditions C Avanti, V Saluja, ELP Van Streun, HW Frijlink, WLJ Hinrichs PLoS One 9 (1), e86244, 2014 | 43 | 2014 |
| Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles V Saluja, MR Visser, W Ter Veer, ML Van Roosmalen, K Leenhouts, ... Vaccine 28 (50), 7963-7969, 2010 | 35 | 2010 |
| Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles V Saluja, MR Visser, ML Van Roosmalen, K Leenhouts, A Huckriede, ... European journal of pharmaceutics and biopharmaceutics 76 (3), 470-474, 2010 | 27 | 2010 |
| Evaluation of the stability of extemporaneously prepared ophthalmic formulation of mitomycin C T Velpandian, V Saluja, AK Ravi, SS Kumari, R Mathur, N Ranjan, ... Journal of Ocular Pharmacology & Therapeutics 21 (3), 217-222, 2005 | 16 | 2005 |
| Bioanalysis and pharmacokinetics of the p38 MAPkinase inhibitor SB202190 in rats J Prakash, V Saluja, J Visser, F Moolenaar, DKF Meijer, K Poelstra, ... Journal of Chromatography B 826 (1-2), 220-225, 2005 | 15 | 2005 |
| Dried influenza vaccines: over the counter vaccines V Saluja, WLJ Hinrichs, HW Frijlink Human vaccines 6 (10), 854-856, 2010 | 5 | 2010 |
| Novel perspectives for influenza vaccine formulation and administration V Saluja Journal of Controlled Release 144 (2), 127-33, 2010 | 1 | 2010 |
| Novel perspectives for influenza vaccine formulation and administration: L. lactis cell wall derived adjuvant, stable dry powder vaccines and mucosal vaccine delivery V Saluja | | 2010 |
hinrichs wljVerified email at rug.nl
